Select Page

An Update on a Few of Our Stocks Rough day out there as we write this. Dow down 140 and the S&P 500 down 20 or 0.8%. Nutanix (NTNX: $22.40) is having a good day. It’s at the top today of all of the stocks we follow, up 3%. Just think what a good day it would be having...

MYLAN ADDED TO OPPORTUNITIES IN HEALTHCARE

July 12, 2016: The United States pays the highest prices for prescription drugs of any country in the world. New drugs enjoy long patent protection that allows their makers to set prices at whatever the market will bear. It doesn’t stop there. This content is for our...

CBRE and BREXIT

June 29, 2016: CBRE (CBG: $26, up 3% today) The global leader in real estate services has seen its stock hammered by the Brexit decision. Just this month, the price has fallen from $31, just before the Brexit vote, by 20% to its low on Monday to just under $25. Is...

CELGENE ADDED TO OPPORTUNITIES IN HEALTHCARE

June 27, 2016: Biotech Has Been A Barking Dog. Biotechnology promises to change the fight against major diseases, remove pain and suffering, create high paying jobs and provide prosperity for business and investors. So far many of these promises have come to pass....

TESLA IS BUYING SOLAR CITY

June 22, 2016: Tesla (TSLA: $220) announced a buyout offer for Solar City (SCTY: $21). Tesla is down to $193 in afterhours trading and Solar City is up to $24, after hitting $25. This content is for our beloved subscribers and anything you see on this page is just an...